How much longer will tumour cells fool the immune system?

In spite of successful control of tumour growth in mice, immunotherapy has yielded disappointing results in patients with malignant diseases. A recent meeting * * The Workshop ‘Tumour escape from immune recognition: molecular mechanisms and functional significance’ was held in Baltimore, MD, USA, on...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Immunology today (Amsterdam. Regular ed.) 2000-02, Vol.21 (2), p.70-72
Hauptverfasser:	Ferrone, Soldano, Finerty, John F., Jaffee, Elizabeth M., Nabel, Gary J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal - metabolism Antigens - immunology Antigens, Neoplasm - metabolism Costimulatory molecules fas Receptor - physiology Fas-Fas ligand Genetic Variation - genetics HLA antigens HLA Antigens - genetics HLA Antigens - metabolism Humans Immune Tolerance Immunotherapy Neoplasms - immunology Neoplasms - metabolism Oligopeptides - genetics Oligopeptides - metabolism T-Lymphocytes - immunology Tumor antigens Tumor escape
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In spite of successful control of tumour growth in mice, immunotherapy has yielded disappointing results in patients with malignant diseases. A recent meeting * * The Workshop ‘Tumour escape from immune recognition: molecular mechanisms and functional significance’ was held in Baltimore, MD, USA, on 22–23 August, 1999. focused on the mechanisms used by tumours to escape immune recognition and the implications for cancer immunotherapy.
ISSN:	0167-5699
DOI:	10.1016/S0167-5699(99)01569-8